Provided by Tiger Trade Technology Pte. Ltd.

KALA BIO

0.8201
-0.0200-2.38%
Post-market: 0.82010.00000.00%19:42 EDT
Volume:100.68K
Turnover:86.50K
Market Cap:15.86M
PE:-0.13
High:0.9840
Open:0.9840
Low:0.8000
Close:0.8401
52wk High:1,030.00
52wk Low:0.5900
Shares:19.34M
Float Shares:18.59M
Volume Ratio:1.75
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.3408
EPS(LYR):-165.5565
ROE:-345.32%
ROA:-65.43%
PB:1.75
PE(LYR):0.00

Loading ...

Kala Bio Q2 EPS $(21.32) Up From $(85.64) YoY, Sales $0.00, Same YoY

Benzinga Earnings
·
Aug 20

Kala Bio Q2 Net Loss Narrows to $1.58 Million from Year-Ago $11.16 Million

Reuters
·
Aug 20

KALA BIO Announces Brief Delay in Quarterly Filing

TIPRANKS
·
Aug 15

Kala Bio Delays Q2 Form 10-Q Filing, Cites Added Time for Liquidity Disclosure

Reuters
·
Aug 14

Kala Bio Files ATM Offering of up to $250 Million in Common Stock - SEC Filing

Reuters
·
Jul 23

KALA BIO Files Atm Offering of up to $250.00 Mln in Common Stock - SEC Filing

THOMSON REUTERS
·
Jul 23

Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate

Benzinga Earnings
·
May 16

Kala Bio Q1 FY26 net loss narrows to $1.62 million

Reuters
·
May 16

Kala Bio falls -21.7%

TIPRANKS
·
May 13

KALA BIO Inc - May Offer up to $350 Mln in Securities - SEC Filing

THOMSON REUTERS
·
May 08

Kala Bio to execute 1-for-50 reverse stock split May 8

Reuters
·
May 07

KALA BIO Inc - Announces 1-for-50 Reverse Stock Split

THOMSON REUTERS
·
May 07

Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

GlobeNewswire
·
Apr 28

Kala Bio ‘celebrates’ U.S. Executive Order for psychedelic medicine

TIPRANKS
·
Apr 21

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

GlobeNewswire
·
Apr 21

Kala Bio Q4 EPS $0.86 Beats $(1.44) Estimate, Sales $0.00

Benzinga Earnings
·
Apr 16

Kala Bio FY25 net loss narrows 30% to $27 million

Reuters
·
Apr 16

Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

GlobeNewswire
·
Apr 01

Kala Bio delays filing annual report, cites management turnover and strategic shift

Reuters
·
Apr 01

KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live

GlobeNewswire
·
Mar 30